CB1 receptor antagonists: new discoveries leading to new perspectives
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CB1 receptor antagonists: new discoveries leading to new perspectives
Authors
Keywords
-
Journal
Acta Physiologica
Volume 205, Issue 1, Pages 41-60
Publisher
Wiley
Online
2011-12-27
DOI
10.1111/j.1748-1716.2011.02402.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of blockage of the endocannabinoid system by CB1 antagonism on cardiovascular risk
- (2014) François Mach et al. Pharmacological Reports
- Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity
- (2014) Carlos E. Leite et al. Pharmacological Reports
- The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited
- (2011) Katja Karg et al. ARCHIVES OF GENERAL PSYCHIATRY
- Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice
- (2011) Sudhir N. Umathe et al. BEHAVIOURAL BRAIN RESEARCH
- Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies
- (2011) Sara Jane Ward et al. Obesity
- Pharmacotherapy for Obese Adolescents
- (2011) Donald E. Greydanus et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Personalized medicine can pave the way for the safe use of CB1 receptor antagonists
- (2011) Judit Lazary et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
- (2010) Matthew J. Taylor et al. BIOLOGICAL PSYCHIATRY
- The pharmacogenetics of antidepressant-induced mania: a systematic review and meta-analysis
- (2010) Federico M Daray et al. BIPOLAR DISORDERS
- Headache-type adverse effects of NO donors: vasodilation and beyond
- (2010) G Bagdy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
- (2010) John H. Krystal et al. CNS DRUGS
- Combination Drugs for Treating Obesity
- (2010) Frank L. Greenway et al. Current Diabetes Reports
- Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
- (2010) Ari Illi et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial
- (2010) Louis J. Aronne et al. Obesity
- A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain
- (2009) Nancy A. Rigotti et al. ADDICTION
- Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with5-HTTLPRaffect the anxious phenotype
- (2009) Judit Lazary et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
- (2009) Fabrício A. Moreira et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood–brain-barrier
- (2009) Jean-Marie Receveur et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Moderation of antidepressant response by the serotonin transporter gene
- (2009) Patricia Huezo-Diaz et al. BRITISH JOURNAL OF PSYCHIATRY
- What are the risks and the benefits of current and emerging weight-loss medications?
- (2009) Jamie R. Robinson et al. Current Diabetes Reports
- Pleiotropic Effects of Rimonabant: Clinical Implications
- (2009) Jean-Pierre Despres CURRENT PHARMACEUTICAL DESIGN
- Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
- (2009) Eduard Maron et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Melancholic features related to rimonabant
- (2009) Bernardo de Mattos Viana et al. GENERAL HOSPITAL PSYCHIATRY
- Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control
- (2009) M-H Son et al. INTERNATIONAL JOURNAL OF OBESITY
- Paracrine Transactivation of the CB1Cannabinoid Receptor by AT1Angiotensin and Other Gq/11Protein-coupled Receptors
- (2009) Gábor Turu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results
- (2009) Luis M Ruilope et al. JOURNAL OF HYPERTENSION
- Lack of CB1receptor activity impairs serotonergic negative feedback
- (2009) Ester Aso et al. JOURNAL OF NEUROCHEMISTRY
- The role of genetic variation in the causation of mental illness: an evolution-informed framework
- (2009) R Uher MOLECULAR PSYCHIATRY
- CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms
- (2009) Gabriella Juhasz et al. NEUROPSYCHOPHARMACOLOGY
- Variations in the cannabinoid receptor 1 gene predispose to migraine
- (2009) Gabriella Juhasz et al. NEUROSCIENCE LETTERS
- The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients
- (2009) Kim M. Smits et al. PSYCHIATRIC GENETICS
- The psychiatric side-effects of rimonabant
- (2009) Fabrício A. Moreira et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
- (2009) Matthew N. Hill et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies
- (2008) Bernard Le Foll et al. ADDICTION BIOLOGY
- The Discovery of Taranabant, a Selective Cannabinoid‐1 Receptor Inverse Agonist for the Treatment of Obesity
- (2008) William K. Hagmann ARCHIV DER PHARMAZIE
- Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk
- (2008) Jean-Pierre Després et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat
- (2008) Jean-Pierre Després et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New Evidence for the Association of the Serotonin Transporter Gene (SLC6A4) Haplotypes, Threatening Life Events, and Depressive Phenotype
- (2008) Judit Lazary et al. BIOLOGICAL PSYCHIATRY
- Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter Polymorphism
- (2008) Francis E. Lotrich et al. BIOLOGICAL PSYCHIATRY
- Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice
- (2008) Jesse LoVerme et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients: Effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes
- (2008) J. Rosenstock et al. DIABETES CARE
- Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program
- (2008) L. Van Gaal et al. DIABETES CARE
- Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
- (2008) V. Di Marzo et al. DIABETOLOGIA
- Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population
- (2008) Xenia Gonda et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Evidence for a novel functional role of cannabinoid CB2receptors in the thalamus of neuropathic rats
- (2008) M. D. Jhaveri et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Central Versus Peripheral Antagonism of Cannabinoid CB1 Receptor in Obesity: Effects of LH-21, a Peripherally Acting Neutral Cannabinoid Receptor Antagonist, in Zucker Rats
- (2008) F. J. Pavón et al. JOURNAL OF NEUROENDOCRINOLOGY
- Functional polymorphisms in the interleukin-6 and serotonin transporter genes and depression and fatigue induced by interferon-α and ribavirin treatment
- (2008) S J Bull et al. MOLECULAR PSYCHIATRY
- End of the line for cannabinoid receptor 1 as an anti-obesity target?
- (2008) Dan Jones NATURE REVIEWS DRUG DISCOVERY
- Reciprocal inhibition of G-protein signaling is induced by CB1 cannabinoid and GABAB receptor interactions in rat hippocampal membranes
- (2008) Resat Cinar et al. NEUROCHEMISTRY INTERNATIONAL
- How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems
- (2008) Dennis L. Murphy et al. NEUROPHARMACOLOGY
- Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats
- (2008) T JARBE et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cost-Utility Analysis of Rimonabant in the Treatment of Obesity
- (2008) Christian Hampp et al. VALUE IN HEALTH
- Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation
- (2007) K L Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus
- (2007) Tamás Balázsa et al. NEUROCHEMISTRY INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started